Can FDA reform drug reviews?

被引：0

作者：

Bunk, S ^{[1
]}

机构：

[1] The Scientist, Philadelphia, PA 19104 USA

来源：

SCIENTIST | 1998年 / 12卷 / 06期

关键词：

D O I：

暂无

中图分类号：

G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];

学科分类号：

1205 ; 120501 ;

摘要：

FACING a challenge: A recent visit to a Food and Drug Administration regional office highlights the issues confronting the agency as it prepares to implement reforms to its approval process for new drugs and biologics.

引用

页码：1 / +

共 50 条

[1] DRUG APPROVAL PROCESS - MIXED REVIEWS FOR FDA REFORM PLANS
EMBER, L
[J]. CHEMICAL & ENGINEERING NEWS, 1991, 69 (47) : 4 - 5
[2] FDA reviews drug safely
不详
[J]. CHEMISTRY WORLD, 2007, 4 (09): : 20 - 20
[3] FDA reviews drug monitoring system
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2004, 82 (46) : 28 - 28
[4] Posting FDA new drug application reviews
Turner, Erick H.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (08): : 863 - 864
[5] Missing Information in FDA Orphan Drug Application Reviews
Rubin, Rita
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (04): : 334 - 334
[6] Drug Preemption and the Need to Reform the FDA Consultation Process
Gilhooley, Margaret
[J]. AMERICAN JOURNAL OF LAW & MEDICINE, 2008, 34 (04) : 539 - 561
[7] Tracking Quality in Drug Manufacturing: FDA reviews guidance status
[J]. Pharmaceutical Technology, 2013, 37 (10)
[8] IOM: Congress must reform FDA to improve drug safety
Young, Donna
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (21) : 2032 - +
[9] Drug safety reform at the FDA - Pendulum swing of systematic improvement?
McClellan, Mark
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17): : 1700 - 1702
[10] FDA "reform"?
Miller, HI
[J]. SCIENCE, 1998, 279 (5348) : 158 - 159

← 1 2 3 4 5 →